整合素αvβ3介导的甲状腺激素对间充质干细胞在肿瘤血管生成中的作用
本研究探讨三碘甲状腺原氨酸(T3)和甲状腺素(T4)对比四碘甲状腺乙酸(Tetrac)对间充质干细胞(MSCs)在肿瘤血管生成中的作用。体外实验显示T3和T4增加MSCs促血管生成基因表达和NIS介导的放射性碘摄取,其上清显著增强内皮细胞成管,Tetrac及整合素下游信号抑制剂可逆转这些效应。在肝细胞癌原位移植小鼠模型中,甲亢小鼠放射性碘摄取增加,而甲减和Tetrac处理小鼠摄取明显降低。
要点
- T3和T4通过整合素αvβ3增加MSCs促血管生成基因表达并增强内皮成管。
- Tetrac及整合素下游信号抑制剂可逆转甲状腺激素对MSCs的促血管生成效应。
- 甲亢小鼠肿瘤放射性碘摄取增加,甲减和Tetrac处理小鼠摄取明显降低。
核心结论
- 数据提示甲状腺激素通过整合素αvβ3影响MSCs的血管生成信号,并进一步证实Tetrac在肿瘤微环境中的抗血管生成活性。
研究设计与样本
- 体外实验使用原代人MSCs,并工程化表达缺氧反应启动子驱动的钠碘同聚体(NIS)报告基因和血管内皮生长因子(VEGF)启动子的MSCs。
- 体内实验使用肝细胞癌原位移植小鼠模型,通过正电子发射断层扫描成像检测VEGF启动子驱动的NIS表达。
主要发现
- 在肝细胞癌条件培养基存在下,T3和T4增加MSCs中促血管生成基因表达及两种NIS报告MSC系的NIS介导放射性碘摄取。
- 甲状腺激素处理的MSCs上清显著增强内皮细胞成管。
- Tetrac和/或整合素下游信号通路抑制剂逆转所有这些效应。
- 体内肿瘤放射性碘摄取显示MSCs成功募集到肿瘤并驱动VEGF启动子驱动的NIS表达。
- 甲亢小鼠较甲功正常小鼠放射性碘摄取增加,而甲减和Tetrac处理小鼠示踪剂摄取明显降低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Several clinical and experimental studies have implicated thyroid hormones in cancer progression. Cancer-relevant effects, including stimulation of tumor growth and new blood vessel formation by angiogenesis, are thought to be mediated by a nonclassical signaling pathway initiated through integrin αvβ3 expressed on cancer cells and proliferating endothelium. In an earlier study, we established mesenchymal stem cells (MSCs), important contributors to the fibrovascular network of tumors, as new thyroid hormone-dependent targets. Here, we evaluated the effects of the thyroid hormones triiodothyronine (T3) and thyroxine (T4) versus Tetrac, an integrin-specific inhibitor of thyroid hormone action, on MSCs in tumor angiogenesis. Methods: Modulation of the expression and secretion of angiogenesis-relevant factors by thyroid hormones in primary human MSCs and their effect on endothelial cell tube formation were tested in vitro. We further engineered MSCs to express the sodium iodide symporter (NIS) reporter gene under control of a hypoxia-responsive promoter and the vascular endothelial growth factor (VEGF) promoter to test effects on these pathways in vitro and, for VEGF, in vivo in an orthotopic hepatocellular carcinoma (HCC) xenograft mouse model by positron emission tomography imaging. Results: T3 and T4 increased the expression of pro-angiogenic genes in MSCs and NIS-mediated radioiodide uptake in both NIS reporter MSC lines in the presence of HCC cell-conditioned medium. Supernatant from thyroid hormone-treated MSCs significantly enhanced endothelial cell tube formation. Tetrac and/or inhibitors of signaling pathways downstream of the integrin reversed all these effects. Tumoral radioiodide uptake in vivo demonstrated successful recruitment of MSCs to tumors and VEGF promoter-driven NIS expression. Hyperthyroid mice showed an increased radioiodide uptake compared with euthyroid mice, while tracer uptake was markedly reduced in hypothyroid and Tetrac-treated mice. Conclusions: Our data suggest that thyroid hormones influence angiogenic signaling in MSCs via integrin αvβ3 and further substantiate the anti-angiogenic activity of Tetrac in the tumor microenvironment.
引用
- Schmohl KA, Mueller AM, Dohmann M, et al. Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis. Thyroid. 2019. PMID: 31816265. doi:10.1089/thy.2019.0413
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。